You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Loxo Oncol Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Loxo Oncol
International Patents:193
US Patents:10
Tradenames:2
Ingredients:2
NDAs:3

Drugs and US Patents for Loxo Oncol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loxo Oncol JAYPIRCA pirtobrutinib TABLET;ORAL 216059-002 Jan 27, 2023 RX Yes Yes 12,109,193 ⤷  Sign Up Y ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-001 May 8, 2020 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol JAYPIRCA pirtobrutinib TABLET;ORAL 216059-001 Jan 27, 2023 RX Yes No 10,342,780 ⤷  Sign Up Y Y ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-001 May 8, 2020 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib TABLET;ORAL 218160-003 Apr 10, 2024 RX Yes No 10,112,942 ⤷  Sign Up Y Y ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib TABLET;ORAL 218160-003 Apr 10, 2024 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol JAYPIRCA pirtobrutinib TABLET;ORAL 216059-002 Jan 27, 2023 RX Yes Yes 10,918,622 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Loxo Oncol Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3390395 2024C/506 Belgium ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; AUTHORISATION NUMBER AND DATE: EU/1/23/1738 20231031
3390395 CR 2024 00006 Denmark ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; REG. NO/DATE: EU/1/23/1738 20231031
3390395 C03390395/01 Switzerland ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68733 30.11.2023
3390395 301262 Netherlands ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; REGISTRATION NO/DATE: EU/1/23/1738 20231031
3390395 4/2024 Austria ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; REGISTRATION NO/DATE: EU/1/23/1738 (MITTEILUNG) 20231031
3390395 PA2024506 Lithuania ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIBAS; REGISTRATION NO/DATE: EU/1/23/1738 20231030
3390395 122024000010 Germany ⤷  Sign Up PRODUCT NAME: PIRTOBRUTINIB; REGISTRATION NO/DATE: EU/1/23/1738 20231031
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.